Eli Lilly's stock dropped nearly 2 points after Sanders criticized the company's pricing.

Sanders got a rough reception at a private meeting with House Democrats.

Eli Lilly Alzheimers Drug Fails Major Test Trial   A drug developed by Eli Lilly to treat patients with Alzheimers disease symptoms failed a closely watched clinical trial. WSJs Jeanne Whalen explains the impact of the failure on Eli Lilly stock and the rest of the pharmaceutical sector which had rested its hopes on the success of the drug. Photo: Kris Tripplaar/Sipa USA

Eli Lilly Alzheimer’s Drug Fails Major Test Trial

American Stock Market: ELI LILLY AND COMPANY (NYSE) (LLY) BUY !!

American Stock Market: ELI LILLY AND COMPANY (NYSE) (LLY) BUY !!

Pharma Stocks Plunge After Eli Lilly (LLY) News - YouTube

When you are ready to step up your trading and investing game, enter the InTheMoneyStocks services and get all of the live trades now. The Research Cent.

Eli Lilly (LLY), a major pharmaceutical company, is perhaps the best example. Not many people found Eli Lilly attractive in late 2010 because its stock wasn’t going up. Ironically, the stock has been on a tear ever since, gaining 159% on a total return basis. As a result, Eli Lilly’s valuation is now sky-high. The following chart shows Eli Lilly’s enterprise value-to-EBITDA multiple and price-to-sales ratio over the past 10 years.

Eli Lilly: Sell This Pharmaceutical Stock Before It Goes Limp

Amgen, Biogen, Eli Lilly Poised To Rocket On 'Most Important Event' | Stock News & Stock Market Analysis - IBD

Amgen, Biogen, Eli Lilly Poised To Rocket On 'Most Important Event'

Eli Lilly stock FDA approval - CNBC

Eli Lilly shares are cratering after the FDA rejected a $1 billion arthritis drug on safety concerns

Lilly says the FDA needed additional data to "characterize safety concerns across treatment arms" and to determine "the most appropriate doses.

Eli Lilly shares fall on Bernie Sanders tweet - CNBC

Eli Lilly shares fall on Bernie Sanders tweet

Eli Lilly offices in New Jersey. The company’s stock has risen 40% in the past...

Putting Eli Lilly’s Biotech Bounce to the Test

Eli Lilly Alzheimer’s Drug Fails Trial

Eli Lilly and Co. have announced that their experimental Alzheimer’s treatment has failed to slow mental deterioration in its latest study. Consequently, Lilly shares dropped 11.7 percent on Wednesday.

Eli Lilly and Co. have announced that their experimental Alzheimer’s treatment has failed to slow mental deterioration in its latest study. Consequently, Lilly shares dropped percent on Wednesday.

New diabetes guidelines imminent, Jardiance sales may surge

New diabetes guidelines imminent, Jardiance sales may surge

A screen displays trading information for stocks; Pfizer, Abbott Laboratories, Merck and Company and Eli Lilly and Company on the floor of the New York Stock Exchange (NYSE) in New York City, U., May REUTERS/Brendan McDermid/File Photo

Cramer: Dumping Eli Lilly is a huge mistake http://amapnow.com http://my.gear.host.com http://needava.com http://renekamstra.com

Cramer: Dumping this stock is a huge mistake

Eli Lilly is hoping its newest cancer launch, Portrazza, can keep powering volume gains for the company. But England’s cost-effectiveness gatekeepers are throwing up a hurdle.

Major Pharma Short Interest Takes a Small Step Back -- KingstoneInvestmentsGroup.com

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks short interest decreased.

Point Roberts WA, New York, NY - February 19, 2014 (Investorideas.com Biotech Newswire) Investorideas.com global news source covering leading sectors including biotech and pharma reports on companies in the sector targeting pancreatic cancer. Stocks mentioned include NewLink Genetics (NLNK), Sunshine Biopharma Inc. ( OTCBB: SBFM ), Eli Lilly and Company (NYSE:LLY) and Celgene (NASDAQ:CELG).

Point Roberts WA, New York, NY - February 19, 2014 (Investorideas.com Biotech Newswire) Investorideas.com global news source covering leading sectors including biotech and pharma reports on companies in the sector targeting pancreatic cancer. Stocks mentioned include NewLink Genetics (NLNK), Sunshine Biopharma Inc. ( OTCBB: SBFM ), Eli Lilly and Company (NYSE:LLY) and Celgene (NASDAQ:CELG).

Pinterest
Search